Close Menu

If Technology Review is right, we may have to stop making fun of those DNA-based ancestry sites. According to this article, the popularity of large-scale studies like GWAS is providing markers that appear to be more indicative of actual ancestry than some of the early-days markers that have been used to date. Of course, if the ancestry companies started using high-density arrays to look at hundreds of thousands of regions across the genome ... well, then they'd just be 23andMe.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.